Rentokil Initial plc (the Company)
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
a)
|
Name
|
John Myers |
||||
2
|
Reason for the notification
|
|||||
a)
|
Position/status
|
Managing Director, North America |
||||
b)
|
Initial notification /Amendment
|
Initial notification |
||||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
a)
|
Name
|
Rentokil Initial plc |
||||
b)
|
LEI
|
549300VN4WV7Z6T14K68 |
||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of 1p each
ISIN: GB00B082RF11
|
||||
b)
|
Nature of the transaction
|
Sale of Shares |
||||
c)
|
Price(s) and volume(s)
|
|
||||
d)
|
Aggregated information
- Aggregated volume
- Aggregated price
- Total
|
225,000
538.7214p
£1,212,123.15 |
||||
e)
|
Date of the transaction
|
7 August 2020 |
||||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
Enquiries:
Daragh Fagan, Company Secretary Rentokil Initial plc 01276 607444
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.